Guangdong VTR Bio-Tech Co., Ltd.
Shenzhen Stock ExchangeTotal Valuation
Guangdong VTR Bio-Tech Co., Ltd. carries a market capitalization of 2.78B, placing it among publicly traded companies globally. Its enterprise value stands at 3.12B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.78B |
| Enterprise Value | 3.12B |
Share Statistics
Guangdong VTR Bio-Tech Co., Ltd. currently has 491.06M shares outstanding.
| Shares Outstanding | 491.06M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Guangdong VTR Bio-Tech Co., Ltd. trades at a trailing price-to-earnings ratio of 1,119.31. The price-to-sales ratio is 4.38, and the price-to-book ratio stands at 3.86.
| PE Ratio | 1,119.31 |
| PS Ratio | 4.38 |
| PB Ratio | 3.86 |
| P/TBV Ratio | 1.64 |
| P/FCF Ratio | 12.83 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Guangdong VTR Bio-Tech Co., Ltd. trades at an EV/EBITDA multiple of 334.70 and an EV/FCF ratio of 10.50. The EV/Sales ratio of 3.70 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 334.70 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.70 |
| EV / EBITDA | 334.70 |
| EV / EBIT | 334.70 |
| EV / FCF | 10.50 |
Financial Position
Guangdong VTR Bio-Tech Co., Ltd. maintains a current ratio of 5.52, meaning it holds 5.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.10, indicating elevated leverage, while an interest coverage ratio of 1.65 demonstrates limited ability to service its debt obligations.
| Current Ratio | 5.52 |
| Quick Ratio | 3.20 |
| Debt / Equity | 3.10 |
| Debt / EBITDA | 8.76 |
| Interest Coverage | 1.65 |
Financial Efficiency
| Return on Equity (ROE) | 0.34 |
| Return on Assets (ROA) | 0.11 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 1.13 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.34 |
Taxes
Over the trailing twelve months, Guangdong VTR Bio-Tech Co., Ltd. has paid -1.63M in income taxes, reflecting an effective tax rate of 70.13.
| Income Tax | -1.63M |
| Effective Tax Rate | 70.13 |
Stock Price Statistics
Guangdong VTR Bio-Tech Co., Ltd.'s stock has declined approximately -22.48996% over the past 52 weeks. The 50-day moving average sits at 6.47, while the 200-day moving average is 6.71.
| Beta (5Y) | N/A |
| 52-Week Price Change | -22.48996% |
| 50-Day Moving Average | 6.47 |
| 200-Day Moving Average | 6.71 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Guangdong VTR Bio-Tech Co., Ltd. generated 843.99M in revenue and converted that into 3.31M in net income, yielding earnings per share of 0.01. EBITDA reached 9.32M, while operating income came in at 9.32M.
| Revenue | 843.99M |
| Gross Profit | 374.81M |
| Operating Income | 9.32M |
| Pretax Income | 2.97M |
| Net Income | 3.31M |
| EBITDA | 9.32M |
| EBIT | 9.32M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
Guangdong VTR Bio-Tech Co., Ltd. holds 706.28M in cash and equivalents against 81.63M in total debt, resulting in a net debt position of -509.32M. Total book value stands at 959.35M, with working capital of 999.63M providing operational flexibility.
| Cash & Cash Equivalents | 706.28M |
| Total Debt | 81.63M |
| Net Debt | -509.32M |
| Equity (Book Value) | 959.35M |
| Book Value Per Share | 1.95 |
| Working Capital | 999.63M |
Cash Flow
After subtracting -288.29M in capital expenditures, free cash flow totaled -288.29M - equivalent to -0.59 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -288.29M |
| Free Cash Flow | -288.29M |
| FCF Per Share | -0.59 |
Margins
Guangdong VTR Bio-Tech Co., Ltd. operates with a gross margin of 44.41, reflecting its pricing power and cost economics. The operating margin of 1.10 and net profit margin of 0.39 provide insight into operational efficiency.
| Gross Margin | 44.41 |
| Operating Margin | 1.10 |
| Pretax Margin | 0.35 |
| Profit Margin | 0.39 |
| EBITDA Margin | 1.10 |
Dividends & Yields
The company's payout ratio of 96.49 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.01 |
| Dividend Yield | N/A |
| Payout Ratio | 96.49 |
| Shareholder Yield | 4.18 |
| FCF Yield | 7.79 |
Stock Splits
Guangdong VTR Bio-Tech Co., Ltd.'s most recent stock split took place on October 18, 2016 with a 1:3 split ratio.
| Last Split Date | 10/18/2016 |
| Split Ratio | 1:3 |
Scores
Guangdong VTR Bio-Tech Co., Ltd. posts an Altman Z-Score of 9.27, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 9.27 |